InterviewEli Lilly-backed Insilico eyes beyond pharma with new AI models Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence for drug discovery. "We want to convert our customer base not only from pharma to other companies,…
Continue reading...